Nanoparticle-Based Treatment in Glioblastoma

Glioblastoma (GB) is a malignant glioma associated with a mean overall survival of 12 to 18 months, even with optimal treatment, due to its high relapse rate and treatment resistance. The standardized first-line treatment consists of surgery, which allows for diagnosis and cytoreduction, followed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Roque, Diogo, Cruz, Nuno, Ferreira, Hugo Alexandre, Reis, Catarina Pinto, Matela, Nuno, Herculano-Carvalho, Manuel, Cascão, Rita, Faria, Claudia C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532799/
https://www.ncbi.nlm.nih.gov/pubmed/37763096
http://dx.doi.org/10.3390/jpm13091328

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10532799/
https://www.ncbi.nlm.nih.gov/pubmed/37763096
http://dx.doi.org/10.3390/jpm13091328

Ejemplares similares